Infectious diseases including COVID-19
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Consent to participate in this study was obtained in writing or verbally from the patient or their substitute. Residual specimens of clinical laboratory specimens used in daily practice, or residual specimens collected for other research purposes.
Exclusion criteria
Exclusion criteria: We excluded the following patients Patients who requested to withdraw after giving their consent for the clinical performance test. Regarding the secondary use of samples used in other studies, if there an individual requested the refusal of the sample for secondary use, the sample will be excluded from the target.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Realization of rapid reporting (time from inspection request to report of results within 120 minutes) | — |
Secondary
| Measure | Time frame |
|---|---|
| Concordance rates in comparison to the results measured at the conventional measurement location as a reference | — |
Countries
Japan
Contacts
University of Tsukuba Hospital Department of Infectious Diseases